(Q54702586)

3 June 2018

title

Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. (English)

1 reference

3 June 2018

author name string

Zhang L

1

1 reference

3 June 2018

Shi J

2

1 reference

3 June 2018

Feng J

3

1 reference

3 June 2018

Klocker H

4

1 reference

3 June 2018

Lee C

5

1 reference

3 June 2018

Zhang J

6

1 reference

3 June 2018

publication date

1 January 2004

1 reference

3 June 2018

Prostate Cancer and Prostatic Diseases

published in

1 reference

3 June 2018

volume

7

1 reference

3 June 2018

issue

4

1 reference

3 June 2018

page(s)

327-332

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500750

exact match

0 references

cites work

The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Matrix metalloproteinases: multifunctional contributors to tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Tumor cell interactions with the extracellular matrix during invasion and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

The AP-1 site and MMP gene regulation: what is all the fuss about?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Expression of activated gelatinase in human invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

MT1-MMP and MMP-7 in invasion and metastasis of human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500750

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500750

1 reference

3 June 2018

PubMed ID

15356679

1 reference

3 June 2018